Kind strives to form a new drug development pattern focusing on small molecule targeted drugs and biomacromolecule drugs to treat anemia, cancers, and hard-to-treat diseases.
At Kind, we have aimed to build a vibrant international biopharmaceutical company with diversified innovative capabilities, and we are dedicated to contributing to human health.
We are keen to bring novel, effective, and affordable therapies to global patients to meet unmet medical needs.
Our mission is to be Good to Human, Humble to Science, and Kind to Patients.
Company Details
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Competitors
- MoleculeX Co., Ltd., Antengene.
安道药业 Questions
安道药业's website is http://www.kindpharmaceuticals.com
安道药业's LinkedIn profile is https://www.linkedin.com/company/%E5%AE%89%E9%81%93%E8%8D%AF%E4%B8%9A
安道药业's industry is
Pharmaceutical Manufacturing
安道药业's top competitors are
Moleculex Co., Ltd.,
Antengene.
安道药业's categories are Pharmaceutical Manufacturing
